Faculty Bibliography

There were two attending chest surgeons, not one, ''given that it was President [Bill Clinto],'' Dr. [Joshua Sonett] said. He and his partner, Dr. Kenneth M. Steinglass, the hospital's chief thoracic surgeon, ''helped each other out on this case,'' Dr. Sonett added. ''A large thick rind'' of inflammatory tissue encased the lower lobe of the lung, making the less-invasive procedure impossible, Dr. Sonett said. They next had to release the trapped part of the lung so it could re-expand to its normal size. Dr. Sonett said his team operated in a different area of Mr. Clinton's chest than Dr. Craig R. Smith did in the bypass surgery. ''The two recoveries are really quite independent,'' Dr. Sonett said

Dr. Zvi Y. Fuks, the Manhattan cancer doctor who was arrested yesterday on securities fraud charges stemming from sales of ImClone Systems stock, was the matchmaker who helped make ImClone successful. He arranged a meeting that led to ImClone's licensing of the cancer drug Erbitux, its first and so far only product. Dr. Fuks, who was a member of ImClone's scientific advisory board, and Sabina Ben-Yehuda, 51, were arrested on charges brought in United States District Court in Manhattan stemming from their sales of ImClone stock in 2001. Both are friends of Samuel D. Waksal, an ImClone founder. It is not clear how Dr. Fuks and Samuel Waksal came to know each other. Dr. Waksal knew many people in the medical community in New York, where ImClone is based, and in Israel, where Dr. Fuks went to medical school

The possible case of the nurse in Hanoi takes on particular potential importance because of his occupation. Bloomberg News reported that he had carried the avian influenza patient on a stretcher and provided direct care at a hospital. If tests identify the A(H5N1) strain as the cause of his illness, and other sources of exposure are ruled out, he could become the first health worker to have contracted avian influenza

The incidence of influenza steadily increased in January and February and has not clearly peaked, the Centers for Disease Control and Prevention said

In the third world, measles, which appears as a rash and fever, killed millions of children each year as recently as a decade ago. And many of the 30 million who survived were left blind or with complications that included brain damage and other disabilities. Measles also causes ear infections and pneumonia. Measles tends to be more severe among poorly nourished children, particularly those with low levels of vitamin A. Recommendations call for giving children with measles a dose of vitamin A supplement for two successive days to help prevent eye damage and blindness

The agency also says it is now in closer contact with its counterparts in Britain and other countries. Some members of Congress had criticized the agency for not following up on problems it had found in previous years at the Chiron plant and for therefore being caught by surprise when the British suspended the license. After the British action, the F.D.A. conducted its own inspection and agreed with the British decision that the vaccine's safety could not be guaranteed. It issued Chiron a warning letter. So the American flu vaccine business may not be the moneymaker Chiron envisioned when it entered that business in 2003 by paying $878 million to acquire PowderJect Pharmaceuticals, the British company that owned the Liverpool plant. After its license was suspended, Chiron assembled a team of 70 insiders and outside experts to fix the problem. Just last week, John Lambert, who had headed Chiron's overall vaccine business, resigned. The company is still facing investigations by the Justice Department and the Securities and Exchange Commission

Dr. Thomas R. Frieden, the commissioner of the New York City Department of Health and Mental Hygiene, has reported that the man has the first diagnosed strain of H.I.V. that shows both resistance to multiple classes of antiretroviral drugs and a rapid progression from infection to AIDS. Doctors have in the past reported each component separately, but not in combination. For one, Case B could have infected any number of other people, some never tested for H.I.V., and any of them may have infected Case A. Some contacts may not be openly gay. Also, the identification of anonymous sex contacts solicited through the Internet may come only from a patient's recalling a physical characteristic that the medical detectives must then track down. Many among the 3,900 AIDS experts who participated in the 12th Annual Retrovirus Conference in Boston last week praised Dr. Frieden for sending a warning to people to practice safer sex. As antiretroviral therapy becomes more widely available, drug resistant H.I.V. is likely to spread, speakers said

Health officials around the world have pointed to Uganda's success in reducing the prevalence of infections with HIV, the virus that causes AIDS, in recent years. Uganda's President Yoweri Kaguta Museveni, the [BUSH] administration and some public health experts have credited the decline largely to a policy known as ABC -- for abstinence, be faithful (monogamy) and condom use. The findings apply strictly to Rakai and cannot be extrapolated to other areas of Uganda for many reasons, [Maria J. Wawer] and a co-author, Dr. Ronald Gray of Johns Hopkins, who is also her husband, said in interviews with reporters. One reason is that the age of first sexual intercourse varies in different areas of Uganda. [Chris Beyrer], Wawer and Gray said there now is a condom shortage in Uganda because officials have found defects in condoms imported from a country they did not identify. The Ugandan government has stopped distribution of condoms imported from that country and is testing all foreign-made condoms, including those made in the United States, they said, adding that the price of condoms in Uganda has risen

Charles King, the president of Housing Works, an AIDS support group, said the announcement could be used to demonize the gay lifestyle and accused Dr. [Thomas R. Frieden] of having wanted to change regulations regarding H.I.V. testing for a long time. The Community H.I.V./AIDS Mobilization Project, based in New York, said the link between the spread of the possible new strain and the use of crystal methamphetamine was unproven, and suggested that the city had ignored the ''underlying issues'' behind the spread of the virus, like discrimination, poor housing and unemployment. Dr. Ho, then a relatively unknown 37-year-old researcher fresh from Harvard and U.C.L.A., was hired to run the center in 1989 and immediately attracted attention. With more money at his disposal than most other research institutions, Dr. Ho became the object of envy as top-flight scientists lined up to join his center. Within a few years, Dr. Ho's team won international publicity, challenging long-held theories about AIDS and reporting new evidence about the way the AIDS virus works in the body. After Dr. Frieden disclosed the case, reports of similar cases quickly emerged, some of which had been published earlier. For example, Dr. Julio Montaner, a professor of medicine at the University of British Columbia in Vancouver, reported in 2003 in the scientific journal AIDS that two men with a highly drug-resistant strain of H.I.V. might have progressed rapidly to AIDS. Dr. Ho did not contact Dr. Montaner about the case until three days after Dr. Frieden's news conference

Dr. Guthrie S. Birkhead, director of the New York State Health Department's AIDS Institute, said he discussed the measure with Dr. [Thomas R. Frieden] and was open to considering changing state law. However, Dr. Birkhead and Dr. Frieden said they recognized that because laboratories do not use a standard format to report test results, collecting the data could prove extremely difficult. Immediately after the rare H.I.V. strain was reported to the department, Dr. Frieden said he asked the dozen or so laboratories licensed by the state to check their records for any other patients with the same strain of the virus. While proposals to restructure the AIDS bureau have been in the planning stages for months, they gained added urgency after the city announced last week that a strain of H.I.V. had been found that showed resistance to multiple drugs and possibly led to the rapid onset of AIDS in a New York City man, perhaps in as few as two months